Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020     104,368,000      
Beginning balance at Dec. 31, 2020 $ 997,388   $ 104 $ 408,124 $ 164 $ 588,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4,734     4,734    
Exercise of stock options (in shares)     195,000      
Exercise of stock options 2,383   $ 1 2,382    
Issuance of restricted stock awards (in shares)     27,000      
Forfeiture of restricted stock awards (in shares)     (2,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     25,000      
Shares issued under employee stock purchase plan (in shares)     26,000      
Shares issued under employee stock purchase plan 1,302     1,302    
Common stock redeemed for tax liability (in shares)     (10,000)      
Common stock redeemed for tax liability (966)     (966)    
Other comprehensive gain, net of tax 83       83  
Net income 75,796         75,796
Ending balance (in shares) at Apr. 01, 2021     104,629,000      
Ending balance at Apr. 01, 2021 1,080,720   $ 105 415,576 247 664,792
Beginning balance (in shares) at Dec. 31, 2020     104,368,000      
Beginning balance at Dec. 31, 2020 997,388   $ 104 408,124 164 588,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive gain, net of tax 76          
Net income 158,712          
Ending balance (in shares) at Jul. 01, 2021     105,112,000      
Ending balance at Jul. 01, 2021 1,179,602   $ 105 431,549 240 747,708
Beginning balance (in shares) at Apr. 01, 2021     104,629,000      
Beginning balance at Apr. 01, 2021 1,080,720   $ 105 415,576 247 664,792
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 5,319     5,319    
Exercise of stock options (in shares)     409,000      
Exercise of stock options 3,943   $ 0 3,943    
Issuance of restricted stock awards (in shares)     2,000      
Issuance of common stock upon vesting of restricted stock units (in shares)     2,000      
Shares issued under employee stock purchase plan (in shares)     21,000      
Shares issued under employee stock purchase plan 1,761     1,761    
Issuance of stock related to acquisition (in shares)     50,000      
Issuance of stock related to acquisition 5,000     5,000    
Common stock redeemed for tax liability (in shares)     (1,000)      
Common stock redeemed for tax liability (50)     (50)    
Other comprehensive gain, net of tax (7)       (7)  
Net income 82,916         82,916
Ending balance (in shares) at Jul. 01, 2021     105,112,000      
Ending balance at Jul. 01, 2021 1,179,602   $ 105 431,549 240 747,708
Beginning balance (in shares) at Dec. 30, 2021   105,760,650 105,761,000      
Beginning balance at Dec. 30, 2021 1,323,199   $ 106 450,332 535 872,226
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 5,980     5,980    
Exercise of stock options (in shares)     32,000      
Exercise of stock options 577   $ 0 577    
Issuance of common stock upon vesting of restricted stock units (in shares)     47,000      
Shares issued under employee stock purchase plan (in shares)     21,000      
Shares issued under employee stock purchase plan 1,963     1,963    
Common stock redeemed for tax liability (in shares)     (19,000)      
Common stock redeemed for tax liability (1,807)     (1,807)    
Other comprehensive gain, net of tax 1,554       1,554  
Net income 70,951         70,951
Ending balance (in shares) at Mar. 31, 2022     105,842,000      
Ending balance at Mar. 31, 2022 1,402,417   $ 106 457,045 2,089 943,177
Beginning balance (in shares) at Dec. 30, 2021   105,760,650 105,761,000      
Beginning balance at Dec. 30, 2021 $ 1,323,199   $ 106 450,332 535 872,226
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 240,735          
Other comprehensive gain, net of tax $ 2,376          
Net income 152,783          
Ending balance (in shares) at Jun. 30, 2022   105,992,508 105,993,000      
Ending balance at Jun. 30, 2022 1,494,286   $ 106 466,260 2,911 1,025,009
Beginning balance (in shares) at Mar. 31, 2022     105,842,000      
Beginning balance at Mar. 31, 2022 1,402,417   $ 106 457,045 2,089 943,177
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4,889     4,889    
Exercise of stock options (in shares)     209,000      
Exercise of stock options 4,599   $ 0 4,599    
Forfeiture of restricted stock awards (in shares)     (59,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     5,000      
Common stock redeemed for tax liability (in shares)     (4,000)      
Common stock redeemed for tax liability (273)     (273)    
Other comprehensive gain, net of tax 822       822  
Net income 81,832         81,832
Ending balance (in shares) at Jun. 30, 2022   105,992,508 105,993,000      
Ending balance at Jun. 30, 2022 $ 1,494,286   $ 106 $ 466,260 $ 2,911 $ 1,025,009